Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target IL-9 (clone MH9QL1G). We employs the Lentivirus (EF1α-RFP-β-catenin-NotI) vector components and the SynExpress system of the Coding regions Deletion/Positive feedback for a robust and sustained response against cancers.
Host
Chimeric
Target
IL-9
Clone
MH9QL1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
RFP
Promoter
EF1α
Effector Gene
β-catenin
Insertion Sites
NotI
Gene Modification
Deletion
Modification Domain
Coding regions
Carrier Type
Lentivirus
Transformation Accuracy
0.92
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.